These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23745724)

  • 101. Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood.
    Ohba C; Osaka H; Iai M; Yamashita S; Suzuki Y; Aida N; Shimozawa N; Takamura A; Doi H; Tomita-Katsumoto A; Nishiyama K; Tsurusaki Y; Nakashima M; Miyake N; Eto Y; Tanaka F; Matsumoto N; Saitsu H
    Neurogenetics; 2013 Nov; 14(3-4):225-32. PubMed ID: 24091540
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy.
    Ravenscroft G; Miyatake S; Lehtokari VL; Todd EJ; Vornanen P; Yau KS; Hayashi YK; Miyake N; Tsurusaki Y; Doi H; Saitsu H; Osaka H; Yamashita S; Ohya T; Sakamoto Y; Koshimizu E; Imamura S; Yamashita M; Ogata K; Shiina M; Bryson-Richardson RJ; Vaz R; Ceyhan O; Brownstein CA; Swanson LC; Monnot S; Romero NB; Amthor H; Kresoje N; Sivadorai P; Kiraly-Borri C; Haliloglu G; Talim B; Orhan D; Kale G; Charles AK; Fabian VA; Davis MR; Lammens M; Sewry CA; Manzur A; Muntoni F; Clarke NF; North KN; Bertini E; Nevo Y; Willichowski E; Silberg IE; Topaloglu H; Beggs AH; Allcock RJ; Nishino I; Wallgren-Pettersson C; Matsumoto N; Laing NG
    Am J Hum Genet; 2013 Jul; 93(1):6-18. PubMed ID: 23746549
    [TBL] [Abstract][Full Text] [Related]  

  • 103. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.
    Mirzaa G; Parry DA; Fry AE; Giamanco KA; Schwartzentruber J; Vanstone M; Logan CV; Roberts N; Johnson CA; Singh S; Kholmanskikh SS; Adams C; Hodge RD; Hevner RF; Bonthron DT; Braun KPJ; Faivre L; Rivière JB; St-Onge J; Gripp KW; Mancini GM; Pang K; Sweeney E; van Esch H; Verbeek N; Wieczorek D; Steinraths M; Majewski J; ; Boycot KM; Pilz DT; Ross ME; Dobyns WB; Sheridan EG
    Nat Genet; 2014 May; 46(5):510-515. PubMed ID: 24705253
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Maternal mosaicism underlies the inheritance of a rare germline AKT3 variant which is responsible for megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome in two Roma half-siblings.
    Szalai R; Melegh BI; Till A; Ripszam R; Csabi G; Acharya A; Schrauwen I; Leal SM; Komoly S; Kosztolanyi G; Hadzsiev K
    Exp Mol Pathol; 2020 Aug; 115():104471. PubMed ID: 32446860
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells.
    Yu X; Xu J; Cahuzac KM; Xie L; Shen Y; Chen X; Liu J; Parsons RE; Jin J
    J Med Chem; 2022 Oct; 65(20):14237-14260. PubMed ID: 36197750
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Discovery of Clinical Candidate NTQ1062 as a Potent and Bioavailable Akt Inhibitor for the Treatment of Human Tumors.
    Ma C; Wu J; Wang L; Ji X; Wu Y; Miao L; Chen D; Zhang L; Wu Y; Feng H; Tang Y; Zhou Q; Pei J; Yang X; Xu D; You Q; Xie Y
    J Med Chem; 2022 Jun; 65(12):8144-8168. PubMed ID: 35679512
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
    Huttlin EL; Bruckner RJ; Navarrete-Perea J; Cannon JR; Baltier K; Gebreab F; Gygi MP; Thornock A; Zarraga G; Tam S; Szpyt J; Gassaway BM; Panov A; Parzen H; Fu S; Golbazi A; Maenpaa E; Stricker K; Guha Thakurta S; Zhang T; Rad R; Pan J; Nusinow DP; Paulo JA; Schweppe DK; Vaites LP; Harper JW; Gygi SP
    Cell; 2021 May; 184(11):3022-3040.e28. PubMed ID: 33961781
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions.
    Man A; Di Scipio M; Grewal S; Suk Y; Trinari E; Ejaz R; Whitney R
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540392
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Case report: Progressive pulmonary artery hypertension in a case of megalencephaly-capillary malformation syndrome.
    Yoh Y; Shiohama T; Uchida T; Ebata R; Kobayashi H; Okunushi K; Kato M; Watanabe K; Nakashima M; Saitsu H; Hamada H
    Front Genet; 2023; 14():1221745. PubMed ID: 37614820
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome (MCAP): A Rare Dynamic Genetic Disorder.
    Sarma K; Nayak MK; Mishra B; Gaikwad SB
    Cureus; 2022 May; 14(5):e25123. PubMed ID: 35733479
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Epilepsy in the mTORopathies: opportunities for precision medicine.
    Moloney PB; Cavalleri GL; Delanty N
    Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.
    Pirozzi F; Lee B; Horsley N; Burkardt DD; Dobyns WB; Graham JM; Dentici ML; Cesario C; Schallner J; Porrmann J; Di Donato N; Sanchez-Lara PA; Mirzaa GM
    Am J Med Genet A; 2021 Sep; 185(9):2719-2738. PubMed ID: 34087052
    [TBL] [Abstract][Full Text] [Related]  

  • 113. A
    Wang Y; Peng J; Bai S; Yu H; He H; Fan C; Hao Y; Guan Y
    Front Genet; 2021; 12():596709. PubMed ID: 34040629
    [TBL] [Abstract][Full Text] [Related]  

  • 114. PIK3R2/Pik3r2 Activating Mutations Result in Brain Overgrowth and EEG Changes.
    Shi X; Lim Y; Myers AK; Stallings BL; Mccoy A; Zeiger J; Scheck J; Cho G; Marsh ED; Mirzaa GM; Tao T; Golden JA
    Ann Neurol; 2020 Dec; 88(6):1077-1094. PubMed ID: 32856318
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Burke JE
    Front Immunol; 2018; 9():575. PubMed ID: 29616047
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.
    Alcantara D; Timms AE; Gripp K; Baker L; Park K; Collins S; Cheng C; Stewart F; Mehta SG; Saggar A; Sztriha L; Zombor M; Caluseriu O; Mesterman R; Van Allen MI; Jacquinet A; Ygberg S; Bernstein JA; Wenger AM; Guturu H; Bejerano G; Gomez-Ospina N; Lehman A; Alfei E; Pantaleoni C; Conti V; Guerrini R; Moog U; Graham JM; Hevner R; Dobyns WB; O'Driscoll M; Mirzaa GM
    Brain; 2017 Oct; 140(10):2610-2622. PubMed ID: 28969385
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.
    Negishi Y; Miya F; Hattori A; Johmura Y; Nakagawa M; Ando N; Hori I; Togawa T; Aoyama K; Ohashi K; Fukumura S; Mizuno S; Umemura A; Kishimoto Y; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Nakanishi M; Saitoh S
    BMC Med Genet; 2017 Jan; 18(1):4. PubMed ID: 28086757
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Brain Development and Akt Signaling: the Crossroads of Signaling Pathway and Neurodevelopmental Diseases.
    Wang L; Zhou K; Fu Z; Yu D; Huang H; Zang X; Mo X
    J Mol Neurosci; 2017 Mar; 61(3):379-384. PubMed ID: 28025777
    [TBL] [Abstract][Full Text] [Related]  

  • 119. De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia.
    Terrone G; Voisin N; Abdullah Alfaiz A; Cappuccio G; Vitiello G; Guex N; D'Amico A; James Barkovich A; Brunetti-Pierri N; Del Giudice E; Reymond A
    Eur J Hum Genet; 2016 Aug; 24(9):1359-62. PubMed ID: 26860062
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.